Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Molecular and Cellular Biology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Articles

The Ubiquitin Ligase CHIP Prevents SirT6 Degradation through Noncanonical Ubiquitination

Sarah M. Ronnebaum, Yaxu Wu, Holly McDonough, Cam Patterson
Sarah M. Ronnebaum
aMcAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina, USA
bCurriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaxu Wu
aMcAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Holly McDonough
aMcAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cam Patterson
aMcAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina, USA
cDepartment of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/MCB.00480-13
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Fig 1
    • Open in new tab
    • Download powerpoint
    Fig 1

    SirT6 protein is stabilized in the presence of CHIP. (A) SirT6 expression was analyzed via Western blot analysis in multiple tissues from 12-month-old CHIP+/+ and CHIP−/− mice. Skel., skeletal. (B) Endogenous SirT6 and CHIP protein expression was measured in shControl and shCHIP 293 cells (left) and in CHIP+/+ and CHIP−/− MEFs (right) via Western blot analysis. SirT6 protein quantification (middle) and mRNA quantification (bottom) are shown (n = 4). (C) Normal 293 cells were transiently transfected with control siRNA, two independent siRNAs targeting CHIP, or SirT6 siRNA. CHIP and SirT6 protein were measured via Western blot analysis, and SirT6 protein quantification (middle) and mRNA quantification (bottom) are shown (n = 3). (D) shControl and shCHIP 293 cells stably expressing FLAG-SirT6 were exposed to dimethyl sulfoxide (DMSO), actinomycin, chloroquine, cycloheximide, MG132, or ammonium chloride (NH4Cl) for 16 h. SirT6 protein levels were visualized in Western blots, quantified, and normalized to the DMSO control for each cell type (n = 3). (Right) Representative Western blot from cells treated with MG132. The proteasome-regulated protein p27 is shown to indicate MG132 effectiveness. (E) shCHIP cells were exposed to DMSO or MG132 for 16 h, and Endogenous SirT6 protein levels were measured via Western blotting. p27 indicates MG132 treatment. (Top) Representative Western blot. (Bottom) Quantification (n = 4). Results represent means and SEM. *, P < 0.05. Graphed results represent SirT6 protein relative to β-tubulin and normalized to control in arbitrary units.

  • Fig 2
    • Open in new tab
    • Download powerpoint
    Fig 2

    CHIP and SirT6 stably interact through the CHIP U-box domain. (A) HEK 293 cells were transfected with Myc-tagged CHIP (Myc-WT CHIP) and FLAG-tagged sirtuin isoforms 1 to 7 (FLAG-SirT). Input (above) and FLAG immunoprecipitation (IP) (below) were performed on cell lysates and visualized via Western blotting with the indicated antibodies. (B) Endogenous CHIP was immunoprecipitated from HEK 293 cell lysates, and endogenous SirT6 was detected and visualized via Western blotting. (C) HEK 293 cells transfected with Myc-WT CHIP and FLAG-SirT6 were incubated at 37°C or 42°C for 30 min. Nuclear fractions were immediately prepared, and input and Myc immunoprecipitations were visualized via Western blotting with the indicated antibodies. (D) The indicated Myc-tagged CHIP constructs (diagrammed) were transfected into HEK 293 cells with FLAG-SirT6. Input and Myc immunoprecipitations were performed on cell lysates and visualized via Western blotting. (E and F) shCHIP 293 cells (E) and CHIP−/− MEFs (F) were transfected with Myc-WT CHIP, Myc-ΔU-box CHIP, or Myc-H260Q CHIP. Lysates were collected, and endogenous SirT6 expression was quantified via Western blot analysis (right; n = 4 of each). NS, nonspecific band. The results represent means and SEM. *, P < 0.05. Graphed results represent SirT6 protein relative to β-tubulin and normalized to control in arbitrary units.

  • Fig 3
    • Open in new tab
    • Download powerpoint
    Fig 3

    CHIP ubiquitinates SirT6 with noncanonical chains at K170. (A) shControl and shCHIP 293 cells stably expressing FLAG-SirT6 were transfected with HA-tagged WT ubiquitin (Ub) or HA-tagged K48R ubiquitin and cultured in MG132 for 16 h. Protein levels of input and FLAG-immunoprecipitated samples were visualized via Western blot analysis. The K48R/WT ubiquitination ratio is shown below (n = 3). (B to E) in vitro ubiquitination reactions were performed using recombinant CHIP, SirT6, and ubiquitin. Reaction mixtures containing WT ubiquitin (B), WT ubiquitin or ubiquitin mutants with the indicated lysines mutated to arginine (C), WT ubiquitin or ubiquitin mutants in which the lysine indicated is the only lysine available for ubiquitination (D), or WT ubiquitin or K48-only ubiquitin with the addition of purified 26S proteasome (E) were used to perform ubiquitination reactions and visualized via Western analysis; representative images of at least 3 experiments are shown. (F) Monoubiquitinated SirT6 was analyzed using LC–MS-MS, and a single ubiquitination modification was discovered at K170. (G) in vitro ubiquitination reactions were performed using CHIP, WT ubiquitin, and WT SirT6 or K170R SirT6. For all ubiquitination reactions, representative images are shown (n = 3). The results represent means and SEM. *, P < 0.05. Graphed results represent SirT6 protein relative to β-tubulin and normalized to control in arbitrary units.

  • Fig 4
    • Open in new tab
    • Download powerpoint
    Fig 4

    Mutant SirT6 has improved stability in CHIP-depleted cells. (A) shControl and shCHIP cells were cotransfected with green fluorescent protein (GFP) and WT SirT6 or K170R SirT6. Forty-eight hours later, the levels of transfected proteins were visualized via Western blotting, and SirT6 levels were calculated relative to GFP as an internal transfection control (below; n = 3). (B) Pulse-chase assays using 35S-labeled methionine/cysteine were used to measure protein half-lives of WT SirT6 and K170R SirT6 in shControl and shCHIP cells expressing FLAG-tagged SirT6 constructs. Following FLAG immunoprecipitation and autoradiography, protein levels were calculated at the indicated time points. Representative autoradiography images are shown below the corresponding graphs (n = 3). (C) WT SirT6 and K170R SirT6 were transiently expressed to achieve similar protein expression in shControl and shCHIP 293 cells and then split and treated for 16 h with DMSO or MG132. SirT6 protein levels were measured via Western blotting. The accumulation of WT SirT6 or K170R SirT6 caused by MG132 for each cell condition was quantified and expressed relative to DMSO treatment (below; n = 3). The results represent means and SEM; *, P < 0.05. Graphed results represent SirT6 protein relative to β-tubulin and normalized to control in arbitrary units.

  • Fig 5
    • Open in new tab
    • Download powerpoint
    Fig 5

    CHIP depletion decreases SirT6 and increases H3K9Ac promoter occupancy. (A) H3K9Ac was measured and expressed relative to total H3 via Western blot analysis in shControl and shCHIP 293 cells and in CHIP+/+ and CHIP−/− MEFs. Quantification is shown on the right of each Western blot (n = 3). (B and C) Analysis of H3K9Ac ChIP-seq data from shControl and shCHIP cells was performed by Ingenuity pathway analysis (B) and TRANSFAC (C), using peaks associated with the 5′ regions of annotated genes. (D and E) ChIP-qPCR for endogenous SirT6 (D) and H3K9Ac (E) was performed in shControl cells, shCHIP cells, or shCHIP cells overexpressing WT CHIP (shCHIP+CHIP). Protein enrichment within the promoter regions of the indicated genes was calculated relative to input and normalized to shControl levels (n = 3). (F and G) Real-time PCR was used to measure mRNA in 293 cells used in ChIP studies (F) and livers from CHIP+/+ and CHIP−/− mice (n = 3) (G). (H and I) shControl and shCHIP cells were transfected with vector, WT SirT6, or K170R SirT6 constructs; 48 h later, RNA was isolated. BIRC3 mRNA (H) and LDHB mRNA (I) were measured by qPCR and calculated relative to 18S (n = 3). The results represent means and SEM; *, P < 0.05.

  • Fig 6
    • Open in new tab
    • Download powerpoint
    Fig 6

    Decreased DNA repair in the absence of CHIP is rescued with SirT6 overexpression. (A) CHIP+/+ (white bars) and CHIP−/− (black bars) MEFs were cultured in DMSO, 3-aminobenzamide (3-AB), camptothecin (CTT), or paraquat (PRQ), and viability was assessed using an MTS assay (n = 3). (B) Following drug treatment, MEFs were fixed and stained for γH2AX and DAPI, and foci of >90 nuclei/condition were quantified. The results were clustered by the number of foci per cell and expressed as percentages of the total distribution. (C) Representative images from γH2AX (green) staining. DAPI (blue) is included as a nuclear stain. (D and E) shControl and shCHIP cells stably expressing empty vector or FLAG-SirT6 were treated with MMS (D) or H2O2 (E) for 6 days. The cells were stained with trypan blue and counted, and the percentage of viable cells was calculated (n = 3). (F and G) shControl and shCHIP cells were transiently transfected with vector, WT SirT6, or K170R SirT6. Forty-eight hours later, the cells were exposed to 200 μM MMS (F) or 400 μM H2O2 (G) for 1 h and then allowed to recover for 30 min. Cells were harvested, and the levels of total RPA and RPA phosphorylated at serines 4 and 8 were measured via Western blotting. Quantification of phosphorylated RPA normalized to total RPA is shown below the representative blots (n = 4 for each). The results represent means and SEM; *, P < 0.05.

  • Fig 7
    • Open in new tab
    • Download powerpoint
    Fig 7

    Model of SirT6 protein stability in the presence and absence of CHIP. Our data demonstrate that CHIP stably interacts with SirT6 in a manner dependent on CHIP's U-box domain. SirT6 is noncanonically ubiquitinated at K170 by CHIP, which prevents canonical ubiquitination at K170 and stabilizes SirT6. This allows SirT6 to exert KDAC and DNA repair activities. In the absence of CHIP, the availability of K170 allows canonical ubiquitination by another E3 ligase, leading to proteasomal degradation.

Additional Files

  • Figures
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 -

      Tables S1 (Antibodies), S2 (siRNAs), S3 (ChIP-qPCR primers), and S4 (mRNA primers) and supplemental text

      PDF, 124K

PreviousNext
Back to top
Download PDF
Citation Tools
The Ubiquitin Ligase CHIP Prevents SirT6 Degradation through Noncanonical Ubiquitination
Sarah M. Ronnebaum, Yaxu Wu, Holly McDonough, Cam Patterson
Molecular and Cellular Biology Oct 2013, 33 (22) 4461-4472; DOI: 10.1128/MCB.00480-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Molecular and Cellular Biology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Ubiquitin Ligase CHIP Prevents SirT6 Degradation through Noncanonical Ubiquitination
(Your Name) has forwarded a page to you from Molecular and Cellular Biology
(Your Name) thought you would be interested in this article in Molecular and Cellular Biology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Ubiquitin Ligase CHIP Prevents SirT6 Degradation through Noncanonical Ubiquitination
Sarah M. Ronnebaum, Yaxu Wu, Holly McDonough, Cam Patterson
Molecular and Cellular Biology Oct 2013, 33 (22) 4461-4472; DOI: 10.1128/MCB.00480-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About MCB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #MCBJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0270-7306; Online ISSN: 1098-5549